SinoMab BioScience Limited
HKEX:3681.HK
1.13 (HKD) • At close November 14, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2024 Q2 | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | 2019 Q4 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||
| Current Assets: | |||||||||||
| Cash & Cash Equivalents
| 153.617 | 203.664 | 286.463 | 345.712 | 367.638 | 562.983 | 643.06 | 810.37 | 1,036.496 | 1,200.868 | 196.445 |
| Short Term Investments
| 41.238 | 30.993 | 31.619 | 46.197 | 40.204 | 26.547 | 50.245 | 12.774 | 77.902 | 6.489 | 0 |
| Cash and Short Term Investments
| 194.855 | 234.657 | 318.082 | 422.385 | 407.842 | 589.53 | 693.305 | 916.202 | 1,114.398 | 1,200.868 | 196.445 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 71.201 | 32.655 | 25.441 | 70.905 | 40.121 | 6.155 | 21.417 | 18.152 | 17.085 | 7.685 | 4.309 |
| Total Current Assets
| 266.056 | 270.183 | 343.523 | 447.093 | 447.963 | 595.685 | 735.704 | 934.354 | 1,131.483 | 1,215.042 | 200.754 |
| Non-Current Assets: | |||||||||||
| Property, Plant & Equipment, Net
| 552.63 | 574.659 | 520.29 | 485.817 | 371.724 | 356.207 | 232.955 | 145.923 | 58.352 | 69.123 | 46.131 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 1.173 | 1.844 | 2.067 | 2.595 | 1.928 | 1.921 | 0.248 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 1.173 | 1.844 | 2.067 | 2.595 | 1.928 | 1.921 | 0.248 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 25.079 | 26.933 | 29.922 | 31.897 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 21.943 | 1.1 | -522.357 | -488.412 | -398.731 | -385.061 | -263.125 | -177.82 | -58.352 | 0 | 0 |
| Total Non-Current Assets
| 575.746 | 577.603 | 522.357 | 488.412 | 398.731 | 385.061 | 263.125 | 177.82 | 58.352 | 69.123 | 46.131 |
| Total Assets
| 841.802 | 847.786 | 907.389 | 1,008.348 | 922.115 | 1,041.655 | 1,039.668 | 1,129.523 | 1,221.806 | 1,284.165 | 246.885 |
| Liabilities & Equity: | |||||||||||
| Current Liabilities: | |||||||||||
| Account Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short Term Debt
| 117.225 | 71.251 | 74.436 | 45.801 | 23.56 | 12.394 | 14.795 | 14.13 | 14.287 | 8.04 | 17.104 |
| Tax Payables
| 0 | 0.494 | 0 | 0.569 | 0 | 0.397 | 0 | 0.167 | 0 | 0.029 | 0.097 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 85.471 | 100.901 | 100.405 | 141.021 | 56.203 | 85.573 | 33.141 | 44.507 | 26.887 | 98.606 | 4.005 |
| Total Current Liabilities
| 202.696 | 172.646 | 174.841 | 187.391 | 79.763 | 98.364 | 47.936 | 58.804 | 41.174 | 106.675 | 21.206 |
| Non-Current Liabilities: | |||||||||||
| Long Term Debt
| 362.176 | 379.557 | 326.41 | 311.382 | 273.598 | 263.065 | 188.128 | 83.708 | 76.367 | 45.574 | 28.286 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | -55.88 | -73.024 | -60.536 | -69.288 | -67.585 | -28.247 | -20.423 | 0 | 0 |
| Total Non-Current Liabilities
| 362.176 | 379.557 | 270.53 | 238.358 | 213.062 | 193.777 | 120.543 | 55.461 | 55.944 | 45.574 | 28.286 |
| Total Liabilities
| 564.872 | 552.203 | 501.251 | 498.773 | 353.361 | 361.429 | 236.064 | 142.512 | 117.541 | 152.249 | 49.492 |
| Equity: | |||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 3.621 | 35.939 | 86.352 | 17.348 | 0 | 552.167 | 0 |
| Common Stock
| 1,790.094 | 1,725.211 | 1,725.211 | 1,725.211 | 1,679.126 | 1,679.126 | 1,679.126 | 1,679.126 | 1,679.126 | 1,679.126 | 500.954 |
| Retained Earnings
| -1,580.852 | -1,490.23 | -1,381.215 | -1,247.119 | -1,106.751 | -962.961 | -789.17 | -674.767 | -633.007 | -552.167 | 0 |
| Accumulated Other Comprehensive Income/Loss
| 67.688 | -1,429.628 | 62.142 | 31.483 | -3.621 | -35.939 | -86.352 | -17.348 | 58.146 | -8.132 | -20.277 |
| Other Total Stockholders Equity
| 0 | 0 | 0 | 0 | -0 | -0 | -172.704 | -0 | -633.007 | -1,104.334 | -283.284 |
| Total Shareholders Equity
| 276.93 | 295.583 | 406.138 | 509.575 | 568.754 | 680.226 | 803.604 | 987.011 | 1,104.265 | 1,131.916 | 197.393 |
| Total Equity
| 276.93 | 295.583 | 406.138 | 509.575 | 568.754 | 680.226 | 803.604 | 987.011 | 1,104.265 | 1,131.916 | 197.393 |
| Total Liabilities & Shareholders Equity
| 841.802 | 847.786 | 907.389 | 1,008.348 | 922.115 | 1,041.655 | 1,039.668 | 1,129.523 | 1,221.806 | 1,284.165 | 246.885 |